Asia Pacific Facial Injectable Market Size & Outlook

The facial injectable market in Asia Pacific is expected to reach a projected revenue of US$ 7,681.0 million by 2030. A compound annual growth rate of 16% is expected of Asia Pacific facial injectable market from 2025 to 2030.
Revenue, 2024 (US$M)
$3,181.2
Forecast, 2030 (US$M)
$7,681.0
CAGR, 2025 - 2030
16%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific facial injectable market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific facial injectable market highlights

  • The Asia Pacific facial injectable market generated a revenue of USD 3,181.2 million in 2024.
  • The market is expected to grow at a CAGR of 16% from 2025 to 2030.
  • In terms of segment, botulinum toxin type a was the largest revenue generating product in 2024.
  • Botulinum Toxin Type A is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2025 to 2030.


Asia Pacific data book summary

Market revenue in 2024USD 3,181.2 million
Market revenue in 2030USD 7,681.0 million
Growth rate16% (CAGR from 2025 to 2030)
Largest segmentBotulinum toxin type a
Fastest growing segmentBotulinum Toxin Type A
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCollagen, Botulinum Toxin Type A, HA, CaHA, PLLA


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 25.4% of the global facial injectable market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 7,681.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Facial Injectable Market Companies

Name Profile # Employees HQ Website
Galderma View profile 10001+ Lausanne, Vaud, Switzerland, Europe http://www.galderma.com
Medytox View profile 501-1000 Seoul, Seoul-t'ukpyolsi, South Korea, Asia http://www.medytox.com/page/company_en?site_id=en
Sinclair Pharma plc View profile 501-1000 London, England, United Kingdom, Europe http://www.sinclairpharma.com/
Merz Pharma View profile 5001-10000 Deutsch, Sachsen, Germany, Europe http://www.merz.com
Revance Therapeutics Inc View profile 597 1222 Demonbreun Street, Suite 2000, Nashville, TN, United States, 37203 https://www.revance.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com

Asia Pacific facial injectable market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to facial injectable market will help companies and investors design strategic landscapes.


Botulinum toxin type a was the largest segment with a revenue share of 69.62% in 2024. Horizon Databook has segmented the Asia Pacific facial injectable market based on collagen, botulinum toxin type a, ha, caha, plla covering the revenue growth of each sub-segment from 2018 to 2030.


The Asia-Pacific market is also benefiting from regulatory advancements and product innovations, expanding access to high-quality injectables. For instance, in February 2024, EG Bio Co., LTD, a South Korean company, obtained CE Mark certification for its EDEL X HA Dermal Filler, making it available in the European market. This approval highlights Asia's growing role in aesthetic product innovation and global expansion.

The filler’s advanced formulation with lidocaine ensures a comfortable and painless experience, increasing consumer preference for non-surgical facial rejuvenation. With continuous technological advancements and rising aesthetic awareness, the Asia-Pacific region remains a key growth hub for the Facial Injectable Market.

Reasons to subscribe to Asia Pacific facial injectable market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific facial injectable market databook

  • Our clientele includes a mix of facial injectable market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific facial injectable market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific facial injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific facial injectable market size, by country, 2018-2030 (US$M)

Asia Pacific Facial Injectable Market Outlook Share, 2024 & 2030 (US$M)

Asia Pacific facial injectable market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online